Kesler, Norman & Wride, LLC has filed its latest 13F-HR report, revealing its investment holdings as of September 30, 2026. The firm reported a total value of approximately $643.4 million across 270 positions. This filing is significant as it provides insights into the firm's investment strategies and asset allocations, which may impact its performance in the competitive investment management sector.

Founded in Utah, Kesler, Norman & Wride, LLC operates as a registered investment advisor. The firm focuses on managing investment portfolios for various clients, including institutional investors. The recent filing on November 6, 2026, marks another step in the firm's commitment to transparency and regulatory compliance.

The 13F-HR filing indicates the firm's investment discretion over its holdings, with Garrett Smith serving as the Chief Compliance Officer. The report highlights a diverse range of investments, including significant positions in well-known companies such as Abbott Laboratories, Amazon, and Alphabet Inc. The total reported value of $643,382,739 reflects a robust portfolio that spans various sectors.

This update may influence the firm's clients and stakeholders, as it outlines the strategic direction of their investment choices. Additionally, it provides a benchmark for competitors in the investment management industry, who may analyze Kesler, Norman & Wride's asset allocation to inform their own strategies.

Looking ahead, the filing does not specify any immediate next steps or upcoming events related to the report. However, the firm's ongoing monitoring of its investments and market conditions will likely continue to shape its future filings and investment decisions.